Review article: recurrence of Crohn's disease after surgery – the need for treatment of new lesions
- 31 August 2006
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 24 (s3), 29-32
- https://doi.org/10.1111/j.1365-2036.2006.03056.x
Abstract
Crohn's recurrence is the appearance of objective signs - defined radiologically, endoscopically or pathologically - of Crohn's disease in the bowel of a patient who has previously had a resection of all macroscopically diseased tissue. New lesions can be visualized endoscopically within weeks to months after ileal resection and ileocolonic anastomosis in the neoterminal ileum. The evolution of these lesions mimics the natural history of ileal Crohn's disease at the onset. If we are able to prevent recurrence of early lesions, we will probably interrupt the natural course of the disease. The drugs tested to date include different 5-aminosalicylate formulations, nitro-imidazole antibiotics, steroids and azathioprine. None of these therapies has convincingly been shown to prevent recurrent lesions. Metronidazole and ornidazole are effective, but cannot be used in the long-term because of side effects. Since there is a lag time of months to years between the development of recurrent lesions in the bowel and the recurrence of symptoms, we recommend performing imaging of the bowel 6 months after the operation to assess the severity of recurrence, and basing the further treatment strategy on this assessment.Keywords
This publication has 18 references indexed in Scilit:
- A randomized, double-blind, placebo-controlled trial of the human anti-TNF-α monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn’s diseaseGastroenterology, 2004
- Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's diseaseGastroenterology, 1995
- Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resectionGastroenterology, 1995
- Oral mesalazine (5‐aminosalicylic acid; Asacol) for the prevention of post‐operative recurrence of Crohn's diseaseAlimentary Pharmacology & Therapeutics, 1994
- Early mucosal changes in Crohn's disease.Gut, 1993
- Patterns of Heal Recurrence in Crohnʼs DiseaseAnnals of Surgery, 1992
- Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms.Gut, 1992
- Analysis of clinical course of postoperative recurrence in Crohn's Disease of distal ileumDigestive Diseases and Sciences, 1992
- Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileumThe Lancet, 1991
- Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.Gut, 1984